However, immunocompromised patients at risk for cryptococcal infection appear to have a defect in antibody responses, such as loss of glucuronoxylomannan (GXM), a capsular component reactive B-cells, as well as overall lower levels of peripheral blood memory IgM B cells (69, 70). This evidence concerns the gene CD40LG and cryptococcosis.